These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 23702337)

  • 81. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands.
    Denters MJ; Deutekom M; Fockens P; Bossuyt PM; Dekker E
    BMC Gastroenterol; 2009 Apr; 9():28. PubMed ID: 19393087
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program.
    Chiu HM; Chen SL; Yen AM; Chiu SY; Fann JC; Lee YC; Pan SL; Wu MS; Liao CS; Chen HH; Koong SL; Chiou ST
    Cancer; 2015 Sep; 121(18):3221-9. PubMed ID: 25995082
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Feasibility of immunochemical faecal occult blood testing for colorectal cancer screening in Bulgaria.
    Tsvetanova Dimova R; Dimitrova Dimitrova D; Angelova Levterova B; Stoyanov Dimov R; Atanasova Semerdjieva M; Frantova Tarnovska M; Gencheva Stoyanova R
    J BUON; 2015; 20(2):413-20. PubMed ID: 26011330
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Colorectal cancer screening in high-risk groups is increasing, although current smokers fall behind.
    Oluyemi AO; Welch AR; Yoo LJ; Lehman EB; McGarrity TJ; Chuang CH
    Cancer; 2014 Jul; 120(14):2106-13. PubMed ID: 24737546
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of an equal-access military health system on racial disparities in colorectal cancer screening.
    Changoor NR; Pak LM; Nguyen LL; Bleday R; Trinh QD; Koehlmoos T; Learn PA; Haider AH; Goldberg JE
    Cancer; 2018 Sep; 124(18):3724-3732. PubMed ID: 30207379
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [The populations attitudes to colorectal cancer screening in the Czech Republic].
    Král N; Seifert B; Suchánek Š; Zavoral M; Májek O
    Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):41-6. PubMed ID: 25872995
    [TBL] [Abstract][Full Text] [Related]  

  • 87. An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees.
    Mojica CM; Gunn R; Pham R; Miech EJ; Romer A; Renfro S; Clark KD; Davis MM
    BMC Cancer; 2022 Jan; 22(1):106. PubMed ID: 35078444
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
    Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
    Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Physician counseling on colorectal cancer screening and receipt of screening among Latino patients.
    Nápoles AM; Santoyo-Olsson J; Stewart AL; Olmstead J; Gregorich SE; Farren G; Cabral R; Freudman A; Pérez-Stable EJ
    J Gen Intern Med; 2015 Apr; 30(4):483-9. PubMed ID: 25472506
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Participation rates for organized colorectal cancer screening programmes: an international comparison.
    Klabunde C; Blom J; Bulliard JL; Garcia M; Hagoel L; Mai V; Patnick J; Rozjabek H; Senore C; Törnberg S
    J Med Screen; 2015 Sep; 22(3):119-26. PubMed ID: 25967088
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Association between subject factors and colorectal cancer screening participation in Ontario, Canada.
    Ramji F; Cotterchio M; Manno M; Rabeneck L; Gallinger S
    Cancer Detect Prev; 2005; 29(3):221-6. PubMed ID: 15896925
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study.
    Wei SC; Tsao PN; Wang YT; Lin BR; Wu DC; Tsai WS; Chen JS; Wong JM
    Cancer Med; 2019 Jul; 8(7):3583-3591. PubMed ID: 31063258
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Colorectal cancer screening participation by older women.
    Mandelson MT; Curry SJ; Anderson LA; Nadel MR; Lee NC; Rutter CM; LaCroix AZ
    Am J Prev Med; 2000 Oct; 19(3):149-54. PubMed ID: 11020590
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Wequedong Lodge Cancer Screening Program: implementation of an opportunistic cancer screening pilot program for residents of rural and remote Indigenous communities in Northwestern Ontario, Canada.
    Chow S; Bale S; Sky F; Wesley S; Beach L; Hyett S; Heiskanen T; Gillis KJ; Paroschy Harris C
    Rural Remote Health; 2020 Feb; 20(1):5576. PubMed ID: 32088964
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Colorectal cancer screening: the effectiveness of education on its barriers and acceptability.
    Foo AS; Thia JJ; Ng ZP; Fong NP; Koh GC
    Asia Pac J Public Health; 2012 Jul; 24(4):595-609. PubMed ID: 21490105
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005-2015: After the Introduction of the National Cancer Screening Program.
    Mai TTX; Lee YY; Suh M; Choi E; Lee EY; Ki M; Cho H; Park B; Jun JK; Kim Y; Oh JK; Choi KS
    Yonsei Med J; 2018 Nov; 59(9):1034-1040. PubMed ID: 30328317
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Reasons For Lack of Follow-up Colonoscopy Among Persons With A Positive Fecal Occult Blood Test Result: A Qualitative Study.
    Llovet D; Serenity M; Conn LG; Bravo CA; McCurdy BR; Dubé C; Baxter NN; Paszat L; Rabeneck L; Peters A; Tinmouth J
    Am J Gastroenterol; 2018 Dec; 113(12):1872-1880. PubMed ID: 30361625
    [TBL] [Abstract][Full Text] [Related]  

  • 98. An innovative strategy to reach the underserved for colorectal cancer screening.
    Briant KJ; Espinoza N; Galvan A; Carosso E; Marchello N; Linde S; Copeland W; Thompson B
    J Cancer Educ; 2015 Jun; 30(2):237-43. PubMed ID: 25002255
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
    Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
    BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The long term participation trend for the colorectal cancer screening after the 2011 triple disaster in Minamisoma City, Fukushima, Japan.
    Saito H; Ozaki A; Murakami M; Nishikawa Y; Sawano T; Fujioka S; Shimada Y; Zhao T; Oikawa T; Kanazawa Y; Tsubokura M
    Sci Rep; 2021 Dec; 11(1):23851. PubMed ID: 34903779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.